By screening for suppression of AP-1 activity and AP-1 target gene expression, KITENIN–ErbB4 interaction, and cell invasion of Caco2 CRC and MDA-MB231 breast cancer cells, we identified five candidate compounds (Additional file 1: Fig. S1A). Here, VANGL1 is linked to breast cancer.